Predictors | Event/p-M | IR/100P-Y | CIRR(95%CI) | p.value | AIRR(95%CI) |
---|---|---|---|---|---|
Over all | 39/9766 | 4.79 | – | – | – |
Program | |||||
UTT | 6/ 3417 | 2.10 | 0.33 (0.11–0.81) | 0.003 | 0.25 (0.08–0.70)* |
Differed | 33/6349 | 6.23 | 1 | 1 | |
Age | – | – | 1.01 (0.97–1.04) | 0.622 | – |
Sex | |||||
Male | 14/3134 | 5.36 | 1.18 (0.56–2.37) | 0.230 | 1.33 (0.64–2.75) |
Female | 25/6632 | 4.52 | 1 | 1 | |
Residence | |||||
Rural | 26/ 4094 | 7.6 | 2.77 (1.42–5.38) | 0.001 | 1.58 (0.82–3.05) |
Urban | 13/5672 | 2.75 | 1 | ||
Employment | |||||
Employed | 21/6999 | 3.60 | 1 | 1 | |
Unemployed | 18/2767 | 7.80 | 2.16 (1.34–5.10) | 0.001 | 2.2 (0.82–4.54) |
Marital status | |||||
Married | 23/4920 | 5.60 | 1.41 (0.71–2.86) | 0.14 | 1.73 (0.88–3.40) |
Unmarried | 16/4846 | 3.96 | 1 | 1 | |
Educational status | |||||
Illiterate | 16/3680 | 5.22 | 1.15 (0.56–2.27) | 0.33 | |
Literate | 23/ 6086 | 4.53 | 1 | ||
Weight | – | – | 0.97 (0.94–1.00) | 0.110 | 0.97 (0.94–1.01) |
WHO stage | |||||
Stage I/II | 9/3600 | 3.00 | 0.51 (0.26–0.96) | 0.018 | 0.70 (0.61–0.94)* |
Stage III/IV | 30/6166 | 5.84 | 1 | 1 | |
IPT | |||||
Yes | 15/6800 | 2.64 | 0.27 (0.18–0.56) | 0.001 | 0.35 (0.22–0.48)* |
No | 24/2966 | 9.71 | 1 | 1 | |
Treatment failure | |||||
Yes | 5/ 422 | 14.2 | 3.25 (1.10–8.36) | 0.015 | 5.80 (1.93–8.46)* |
No | 34/ 9344 | 4.37 | 1 | 1 | |
Base line CD4 count | – | – | 0.99 (0.98–1.00) | 0.050 | 0.96(.94–0.99)* |